Anthropic has this week introduced new Claude capabilities for professionals using Excel and PowerPoint, aimed at streamlining workflows in data-driven projects. One key feature is Claude’s new Skill ...

There’s no greater feeling than strolling through the aisles of Sam’s Club and finding a brand-new release, such as the recent Peanut Butter Chocolate Lover’s Trail Mix, new heat-and-eat High Protein ...

BOTTOM LINE: Sam Houston and New Mexico State meet in the CUSA Tournament. The Bearkats are 13-7 against CUSA opponents and 8-3 in non-conference play. Sam Houston averages 83.0 points while ...

Love beer and Boston sports? Sam Adams has just the right brew for you. According to a press release, the one-of-a-kind, limited-edition pack is "a true hometown collaboration celebrating the teams, ...

Love beer and Boston sports? Sam Adams has just the right brew for you. On Monday, Boston brewery Samuel Adams dropped the “Our City. Our Beer.” variety pack in collaboration with four Boston sports ...

In this episode of eSpeaks, Jennifer Margles, Director of Product Management at BMC Software, discusses the transition from traditional job scheduling to the era of the autonomous enterprise. eSpeaks’ ...

HALL COUNTY, Ga. — The Hall County District Attorney’s Office says it will seek the death penalty against a woman charged in the murder of a 4-year-old. A grand jury indicted Jessica Motes on murder, ...

Longtime fans of Dropout (formerly known as CollegeHumor) would say that to call the comedy streaming service a liberal-leaning platform is an understatement. That’s why some viewers were taken aback ...

Vertex Pharmaceuticals is the leader in cystic fibrosis treatment. The company has also expanded into other areas in recent years, winning approval for two new drugs. Vertex is the global leader in ...

EyePoint (EYPT), Janux (JANX), Kyverna (KYTX), and Viking (VKTX) have analyst targets implying 179% to 384% upside. Janux and Kyverna hold the highest upside projections at 384% and 308% respectively, ...

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

The payout ratio for the dividend "is obviously below the dividend commitment" as EPS outlook does not support current dividend levels; capital allocation, including the dividend, is under review. Net ...